Clinical Trial Update: Different Cycles of High-dose Dexamethasone for Initial Management of Primary Immune Thrombocytopenia (ITP) [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating different cycles of high-dose dexamethasone for initial management of immune thrombocytopenia has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)

Snippet

Sponsor: Shandong University | Conditions: Immune Thrombocytopenia | Phase 4 | Status: WITHDRAWN